Senators Press EPA for Action on PFAS

February 18, 2020 by Dan McCue
Senators Press EPA for Action on PFAS
U.S. Capitol, January 16, 2020. (Photo by Dan McCue)

A year after the EPA pledged to act on limiting exposure to a class of extremely hazardous chemicals, a group of Senators is asking why the agency has yet to fulfill its commitments and when it plans to do so.

The group, comprised of 30 Senators, sent a letter Tuesday to EPA administrator Andrew Wheeler requesting he provide an updated timeline for when the agency will implement its strategy for limiting human exposure to exposure to per- and polyfluoroalkyl substances.

The EPA released its plan – the PFAS Action Plan – over one year ago and has yet to act on it.

“As you are aware, communities across the country are struggling to respond to the widespread issue of PFAS contamination. The human health risks from this class of chemicals, which include birth defects, various forms of cancer, and immune system dysfunction, are still being examined, and the uncertainty has caused great concern among our constituents,” the senators wrote.

In March 2019, legislation was introduced in the Senate to declare PFAS as hazardous substances under the EPA Superfund law. The designation would allow federal funds to be used to clean up groundwater contamination due to PFAS spills and mandate responsible parties report spills of PFAS and be held liable for cleanup.

In December, Sen. Sherrod Brown, D-Ohio, one of the letter’s signers, secured provisions in the National Defense Authorization Act – which was signed into law – that would include tougher standards to crack down on PFAS contamination and require the DOD to be more transparent with communities affected by the contamination.

“The health and environmental threats posed by PFAS are significant,” the senators’ letter concludes. “Communities across America demand that the EPA help protect them from PFAS exposure. They deserve the confidence that their water is safe and free from harmful levels of PFAS contamination.”

In addition to Brown, the letter was also signed by Sens. Jeanne Shaheen, D-N.H., Kirsten Gillibrand, D-N.Y., Chuck Schumer, D-N.Y., Tom Carper, D-Del., Debbie Stabenow, D- Mich., Bob Casey, D-Pa., Tina Smith, D-Minn., Jack Reed, D-R.I., Richard Blumenthal, D-Conn., Maggie Hassan, D-N.H., Jeff Merkley, D-Ore., Angus King, I-Maine, Ed Markey, D-Mass., Dianne Feinstein, D-Calif., Tammy Baldwin, D-Wis., Sheldon Whitehouse, D-R.I., Dick Durbin, D-Ill., Amy Klobuchar, D-Minn., Michael Bennet, D-Colo., Patty Murray, D-Wash., Cory Booker, D-N.J., Bernie Sanders, I-Vt., Joe Manchin, D-W.Va., Tammy Duckworth, D-Ill., Ben Cardin, D-Md., Kamala Harris, D-Calif., Chris Coons, D-Del., and Maria Cantwell, D-Wash.

A+
a-
  • EPA
  • polyfluoroalkyl
  • Senate
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top